ACCESS REALMONEY
Email This Article
Headlines & Perspectives
Cephalon: 'Not Surprised' by FDA Panel Vote
By
Elizabeth Trotta
05/06/08 - 06:57 PM EDT
The biotech doesn't expect financial impact in 2008 from an FDA panel's recommendation against expanded use of pain drug Fentora.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
Sign up for our FREE newsletters now.
Keep on top of the market and the critical information you need to make more profitable investing decisions.
